Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

United Health Products (UEEC) Shares Outstanding (Weighted Average) (2016 - 2025)

United Health Products (UEEC) has disclosed Shares Outstanding (Weighted Average) for 13 consecutive years, with $239.1 million as the latest value for Q4 2023.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 4.08% to $239.1 million in Q4 2023 year-over-year; TTM through Dec 2023 was $239.1 million, a 4.08% increase, with the full-year FY2023 number at $239.1 million, up 4.08% from a year prior.
  • Shares Outstanding (Weighted Average) was $239.1 million for Q4 2023 at United Health Products, down from $241.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $241.5 million in Q3 2023 to a low of $174.3 million in Q1 2019.
  • A 5-year average of $207.2 million and a median of $223.5 million in 2021 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): rose 25.94% in 2021, then increased 1.55% in 2022.
  • United Health Products' Shares Outstanding (Weighted Average) stood at $175.9 million in 2019, then rose by 4.48% to $183.8 million in 2020, then increased by 22.85% to $225.7 million in 2021, then rose by 1.76% to $229.7 million in 2022, then rose by 4.08% to $239.1 million in 2023.
  • Per Business Quant, the three most recent readings for UEEC's Shares Outstanding (Weighted Average) are $239.1 million (Q4 2023), $241.5 million (Q3 2023), and $229.7 million (Q4 2022).